Free Trial
NASDAQ:SXTP

60 Degrees Pharmaceuticals (SXTP) Stock Price, News & Analysis

60 Degrees Pharmaceuticals logo
$2.52 -0.09 (-3.45%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$2.54 +0.02 (+0.99%)
As of 07/11/2025 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About 60 Degrees Pharmaceuticals Stock (NASDAQ:SXTP)

Key Stats

Today's Range
$2.51
$2.64
50-Day Range
$2.01
$2.96
52-Week Range
$1.41
$35.99
Volume
43,204 shs
Average Volume
577,773 shs
Market Capitalization
$3.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Moderate Buy

Company Overview

60 Degrees Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

SXTP MarketRank™: 

60 Degrees Pharmaceuticals scored higher than 56% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    60 Degrees Pharmaceuticals has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    60 Degrees Pharmaceuticals has only been the subject of 2 research reports in the past 90 days.

  • Read more about 60 Degrees Pharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for 60 Degrees Pharmaceuticals are expected to grow in the coming year, from ($5.09) to ($0.61) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of 60 Degrees Pharmaceuticals is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of 60 Degrees Pharmaceuticals is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about 60 Degrees Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    4.08% of the float of 60 Degrees Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    60 Degrees Pharmaceuticals has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 60 Degrees Pharmaceuticals has recently increased by 49.07%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    60 Degrees Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    60 Degrees Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.08% of the float of 60 Degrees Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    60 Degrees Pharmaceuticals has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 60 Degrees Pharmaceuticals has recently increased by 49.07%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    60 Degrees Pharmaceuticals has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.00 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for 60 Degrees Pharmaceuticals this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, 60 Degrees Pharmaceuticals insiders have bought more of their company's stock than they have sold. Specifically, they have bought $14,400.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    10.27% of the stock of 60 Degrees Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 7.96% of the stock of 60 Degrees Pharmaceuticals is held by institutions.

  • Read more about 60 Degrees Pharmaceuticals' insider trading history.
Receive SXTP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 60 Degrees Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SXTP Stock News Headlines

Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
See More Headlines

SXTP Stock Analysis - Frequently Asked Questions

60 Degrees Pharmaceuticals' stock was trading at $6.45 on January 1st, 2025. Since then, SXTP stock has decreased by 60.9% and is now trading at $2.52.

60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) released its quarterly earnings results on Thursday, May, 15th. The company reported ($1.56) EPS for the quarter, missing the consensus estimate of ($1.31) by $0.25. The firm had revenue of $0.18 million for the quarter, compared to analyst estimates of $0.15 million.

60 Degrees Pharmaceuticals's stock reverse split on Monday, February 24th 2025.A 1-5 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, February 23rd 2025. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

60 Degrees Pharmaceuticals (SXTP) raised $7 million in an initial public offering on Wednesday, July 12th 2023. The company issued 1,400,000 shares at a price of $5.30 per share. WallachBeth Capital LLC acted as the underwriter for the IPO.

Shares of SXTP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that 60 Degrees Pharmaceuticals investors own include Recursion Pharmaceuticals (RXRX), Editas Medicine (EDIT), Pacific Biosciences of California (PACB), Tilray Brands (TLRY), Akanda (AKAN), Better Therapeutics (BTTX) and Honeywell International (HON).

Company Calendar

Last Earnings
5/15/2025
Today
7/11/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SXTP
CIK
1946563
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

High Price Target
$7.00
Low Price Target
$7.00
Potential Upside/Downside
+177.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($50.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.95 million
Net Margins
-1,947.30%
Pretax Margin
-1,947.30%
Return on Equity
N/A
Return on Assets
-174.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.14
Quick Ratio
2.71

Sales & Book Value

Annual Sales
$300 thousand
Price / Sales
12.35
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($6.38) per share
Price / Book
-0.39

Miscellaneous

Outstanding Shares
1,470,000
Free Float
1,322,000
Market Cap
$3.70 million
Optionable
Not Optionable
Beta
2.78
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:SXTP) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners